LDDD Longduoduo Co Ltd
Services-Health Services · OTC · SEC CIK 1892316 · Fiscal year ends 06/30
Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY-71.6%
TTM net income YoY-316.7%
TTM EPS YoY-321.4%
Revenue 3-yr CAGR-38.1%
Net income 3-yr CAGR—
Margins
Gross margin99.1%
Operating margin-88.5%
Net margin-78.3%
FCF margin—
EBITDA margin-79.1%
Returns
ROE-132.6%
ROA-53.9%
ROIC (approx.)—
Asset turnover0.69x
Leverage & solvency
Liabilities / assets80.2%
Debt / equity0.00x
Current ratio1.07x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.44x
Accruals ratio-30.3%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-06-30 | FY20252025-06-30 | FY20242024-06-30 | FY20232023-06-30 | FY20222022-06-30 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.82M | $4.26M | $7.39M | $3.82M | $3.24M |
| Cost of revenue | $16,958 | $91,099 | $173,349 | $591,885 | $1.01M |
| Gross profit | $1.81M | $4.17M | $7.22M | $3.23M | $2.23M |
| SG&A expense | $2.44M | $3.62M | $5.19M | $3.20M | $9.79M |
| Operating income | -$633,181 | $552,679 | $2.03M | $29,238 | -$7.56M |
| Pretax income | -$575,816 | $714,528 | $1.89M | $31,331 | -$7.56M |
| Income tax | $66,451 | $222,268 | $523,207 | $10,246 | $1,576 |
| Net income | -$578,631 | $460,435 | $1.26M | -$39,089 | -$7.56M |
| EBITDA | -$522,517 | $689,969 | $2.13M | $96,976 | -$7.49M |
| EPS (basic) | -0.02 | 0.01 | 0.04 | -0.00 | -0.29 |
| EPS (diluted) | -0.02 | 0.01 | 0.04 | -0.00 | -0.29 |
| Weighted avg. shares (diluted) | 30.02M | 30.01M | 30.01M | 30.00M | 25.62M |
| Balance sheet | |||||
| Cash & equivalents | $1.59M | $1.64M | $1.40M | $1.14M | $356,672 |
| Inventory | — | — | — | $820 | $3,032 |
| Current assets | $1.78M | $1.81M | $1.66M | $1.31M | $424,328 |
| PP&E, net | $213,025 | $280,003 | $353,486 | $152,719 | $109,233 |
| Intangibles | — | — | — | $3,828 | — |
| Total assets | $2.06M | $2.13M | $2.06M | $1.48M | $610,667 |
| Current liabilities | $1.28M | $830,464 | $1.26M | $2.05M | $1.63M |
| Total liabilities | $1.31M | $830,464 | $1.28M | $2.05M | $1.63M |
| Shareholders' equity | $703,691 | $1.18M | $702,515 | -$541,957 | -$928,786 |
| Shares outstanding | 30.02M | 30.02M | 30.01M | 30.00M | 30.00M |
| Cash flow statement | |||||
| Operating cash flow | -$163,109 | $277,365 | $582,282 | $965,337 | $28,572 |
| Capital expenditure | $30,638 | $59,375 | $305,495 | $120,127 | $111,882 |
| Free cash flow | -$193,747 | $217,990 | $276,787 | $845,210 | -$83,310 |
| Investing cash flow | -$30,638 | -$59,375 | -$305,495 | -$125,880 | -$111,882 |
| Financing cash flow | — | — | — | -$143,333 | $179,697 |
| Depreciation & amortization | $110,664 | $137,290 | $102,032 | $67,738 | $65,700 |
| Stock-based compensation | — | — | — | $384,500 | $6.74M |
Free plan shows the latest 5 periods; Pro shows all 6 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.